Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics

"I am honored to lead Nimbus at this pivotal time in the company's evolution," said Abbas Kazimi. "Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I'm particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”

Continue ReadingAbbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics